https://www.dsij.in/dsijarticledetail/this-mid-cap-multibagger-company-invests-in-cell-and-gene-therapy-company-immunoact-30773
0
0
6/1/23 at 9:10am
Organization
Dsij.in
Author
Siddharth Mane
45 words
0
Comments
CAR-T therapy has shown significant success in the western world as a promising treatment option. However, this innovative technology is currently unavailable in India. Through this collaboration,...
You are the first to view
Create an account
or login to join the discussion